Metrikler
Yayın
76
Açık Erişim
1
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (62)
SCI-E, SSCI, AHCI (57)
SCI-E, SSCI, AHCI, ESCI (61)
ESCI (4)
Scopus (57)
TRDizin (4)
Diğer Yayınlar (1)
2025
20251. Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
Ulugut H., Younes K., Montembeault M., Bertoux M., Irish M., Kumfor F., et al.
Communications Medicine
, cilt.5, sa.1, 2025 (ESCI, Scopus)
2025
20252. Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis
Gezegen H., ALAYLIOĞLU M., Şahin E., Swann O., Veleva E., Güven G., et al.
Alzheimer's and Dementia
, cilt.21, sa.7, 2025 (SCI-Expanded, Scopus)
2025
20253. The Comparison of Functional Connectivity in Parkinson's Disease Patients with and without Parkin Gene Mutations
Çebi M., Ay U., Kiçik A., Erdoğdu E., Tepgeç F., UYGUNER Z. O., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.62, sa.2, ss.131-135, 2025 (SCI-Expanded, Scopus, TRDizin)
2023
20234. Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta
Tufekcioglu Z., Lange J., Pedersen K. F., Tysnes O., Alves G., Emre M.
Dementia and Geriatric Cognitive Disorders Extra
, cilt.13, sa.1, ss.39-47, 2023 (ESCI)
2021
20215. Do Alzheimer's Disease Patients Appear Younger than Their Real Age?
Tufekcioglu Z., BİLGİÇ B., Zeylan A. E., Salah A. A., Dibeklioglu H., Emre M.
Dementia and Geriatric Cognitive Disorders
, cilt.49, ss.483-488, 2021 (SCI-Expanded, Scopus)
2020
20206. Characterization of Recessive Parkinson Disease in a Large Multicenter Study
Lesage S., Lunati A., Houot M., Ben Romdhan S., Clot F., Tesson C., et al.
ANNALS OF NEUROLOGY
, cilt.88, sa.4, ss.843-850, 2020 (SCI-Expanded, Scopus)
2020
20207. Functional neural substrates of football fanaticism: Different pattern of brain responses and connectivity in fanatics
Bilgiç B., Kurt E., Makar Ç. C., Ulasoglu-Yildiz Ç., Samancı B., Gurvit H., et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES
, sa.9, ss.480-487, 2020 (SCI-Expanded, SSCI, Scopus)
2019
20198. Amyloid Beta Adsorption Problem with Transfer Plates in Amyloid Beta 1-42 IVD Kits
Dursun E., Alaylıoğlu M., Bilgiç B., Hanağası H. A., Gürvit H., Emre M., et al.
JOURNAL OF MOLECULAR NEUROSCIENCE
, cilt.67, sa.4, ss.534-539, 2019 (SCI-Expanded, Scopus)
2019
20199. Parkinson's Disease Dementia and Lewy Body Disease
Sezgin M., Bilgic B., Tinaz S., Emre M.
SEMINARS IN NEUROLOGY
, cilt.39, sa.2, ss.274-282, 2019 (SCI-Expanded, Scopus)
2018
201810. Use of anti-Parkinson medication during pregnancy: a case series
Tufekcioglu Z., Hanagasi H. A., YALÇIN ÇAKMAKLI G., ELİBOL B., Tokucoglu F. E., Kaya Z. E., et al.
JOURNAL OF NEUROLOGY
, cilt.265, sa.8, ss.1922-1929, 2018 (SCI-Expanded, Scopus)
2018
201811. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale
AKBOSTANCI M. C., Bayram E., Yilmaz V., Rzayev S., ÖZKAN S., Tokcaer A. B., et al.
MOVEMENT DISORDERS CLINICAL PRACTICE
, cilt.5, sa.1, ss.54-59, 2018 (ESCI, Scopus)
2017
201712. Dementia in Parkinson's disease
Hanagasi H. A., Tufekcioglu Z., Emre M.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, cilt.374, ss.26-31, 2017 (SCI-Expanded, Scopus)
2016
201613. A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family
Hanagasi H. A., Giri A., Kartal E., Guven G., Bilgic B., Hauser A., et al.
PARKINSONISM & RELATED DISORDERS
, cilt.29, ss.117-120, 2016 (SCI-Expanded, Scopus)
2016
201614. Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism
Tufekcioglu Z., Cakar A., Bilgic B., Hanagasi H. A., Gurvit H., Emre M.
NEUROCASE
, cilt.22, sa.3, ss.273-275, 2016 (SCI-Expanded, Scopus)
2015
201515. Neuro-Behcet's Disease with Chorea
Gur Ozmen S., Hanagasi H. A., Gurvit H., Emre M., Akman Demir G.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.52, sa.2, ss.200-201, 2015 (SCI-Expanded, Scopus, TRDizin)
2014
201416. Supranuclear Gaze Abnormality in Sporadic-Creutzfeldt Jacob Disease
Gur Ozmen S., Gurvit H., Hanagasi H. A., Alpsan Gokmen M. H., Emre M.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, cilt.51, sa.1, ss.91-92, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201417. Long-term Safety of Rivastigmine in Parkinson Disease Dementia: An Open-Label, Randomized Study
Emre M., Poewe W., De Deyn P. P., Barone P., Kulisevsky J., Pourcher E., et al.
CLINICAL NEUROPHARMACOLOGY
, cilt.37, sa.1, ss.9-16, 2014 (SCI-Expanded, Scopus)
2014
201418. Experience in Alzheimer's Disease Clinical Trials in Turkey
Uresin Y., Ilbars H., Gurvit I. H., Emre M.
GLOBAL CLINICAL TRIALS FOR ALZHEIMER'S DISEASE: DESIGN, IMPLEMENTATION, AND STANDARDIZATION
, ss.277-288, 2014 (SCI-Expanded)
2013
201319. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
Olanow C. W., Kieburtz K., Rascol O., Poewe W., Schapira A. H., Emre M., et al.
MOVEMENT DISORDERS
, cilt.28, sa.8, ss.1064-1071, 2013 (SCI-Expanded, Scopus)
2013
201320. Parkinson's disease dementia
Bilgic B., Hanagasi H. A., Emre M.
NEUROPSYCHIATRIC AND COGNITIVE CHANGES IN PARKINSON'S DISEASE AND RELATED MOVEMENT DISORDERS: DIAGNOSIS AND MANAGEMENT
, ss.177-191, 2013 (SCI-Expanded)
2013
201321. The ABC of Ataxia Should Also Include the E
Hanagasi H. A., Emre M.
MOVEMENT DISORDERS: UNFORGETTABLE CASES AND LESSONS FROM THE BEDSIDE
, ss.238-239, 2013 (SCI-Expanded)
2013
201322. Neuroimaging, biomarkers, and management of dementia with Lewy bodies
Hanagasi H. A., Bilgic B., Emre M.
FRONTIERS IN NEUROLOGY
, cilt.4, 2013 (SCI-Expanded, Scopus)
2012
201223. Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study
Dubois B., Tolosa E., Katzenschlager R., Emre M., Lees A. J., Schumann G., et al.
MOVEMENT DISORDERS
, cilt.27, sa.10, ss.1230-1238, 2012 (SCI-Expanded, Scopus)
2012
201224. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Litvan I., Goldman J. G., Troester A. I., Schmand B. A., Weintraub D., Petersen R. C., et al.
MOVEMENT DISORDERS
, cilt.27, sa.3, ss.349-356, 2012 (SCI-Expanded, Scopus)
2012
201225. The Impact of Familial Structure on Parkinson's Disease in Istanbul Medical School, Turkey
Lohmann E., Hanagasi H. A., Gurvit H., Kayaci G., Ruberg M., Yazici J., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, cilt.122, sa.2, ss.102-105, 2012 (SCI-Expanded, Scopus)
2012
201226. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone
Reichmann H., Emre M.
EXPERT REVIEW OF NEUROTHERAPEUTICS
, cilt.12, sa.2, ss.119-131, 2012 (SCI-Expanded, Scopus)
2012
201227. Perampanel in Parkinson Disease Fluctuations: A Double-Blind Randomized Trial With Placebo and Entacapone
Rascol O., Barone P., Behari M., Emre M., Giladi N., Olanow C. W., et al.
CLINICAL NEUROPHARMACOLOGY
, cilt.35, sa.1, ss.15-20, 2012 (SCI-Expanded, Scopus)
2011
201128. Cognitive impairment in nondemented Parkinson's disease
Barone P., Aarsland D., Burn D., Emre M., Kulisevsky J., Weintraub D.
MOVEMENT DISORDERS
, cilt.26, sa.14, ss.2483-2495, 2011 (SCI-Expanded, Scopus)
2011
201129. Mild cognitive impairment and cognitive reserve in Parkinson's disease
Poletti M., Emre M., Bonuccelli U.
PARKINSONISM & RELATED DISORDERS
, cilt.17, sa.8, ss.579-586, 2011 (SCI-Expanded, Scopus)
2011
201130. Cognitive Correlates of Visual Hallucinations in Dementia Associated with Parkinson's Disease
Bronnick K., Emre M., Tekin S., Haugen S. B., Aarsland D.
MOVEMENT DISORDERS
, cilt.26, sa.5, ss.824-829, 2011 (SCI-Expanded, Scopus)
2011
201131. Crossed Aphasia in a Dextral Patient With Logopenic/Phonological Variant of Primary Progressive Aphasia
DEMIRTAS-TATLIDEDE A., Gurvit H., OKTEM-TANOR O., Emre M.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
, cilt.23, sa.2, ss.6-7, 2011 (SCI-Expanded, Scopus)
2011
201132. Pain is common in Parkinson's disease
HANAGASI H. A., AKAT S., Gurvit H., Yazici J., Emre M.
CLINICAL NEUROLOGY AND NEUROSURGERY
, cilt.113, sa.1, ss.11-13, 2011 (SCI-Expanded, Scopus)
2011
201133. Treatment of Dementia Associated with Parkinson's Disease
Emre M.
PARKINSON'S DISEASE: NON-MOTOR AND NON-DOPAMINERGIC FEATURES
, ss.163-169, 2011 (SCI-Expanded)
2010
201034. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
Emre M., Tsolaki M., Bonuccelli U., Destee A., Tolosa E., Kutzelnigg A., et al.
LANCET NEUROLOGY
, cilt.9, sa.10, ss.969-977, 2010 (SCI-Expanded, Scopus)
2010
201035. Early-Onset L-dopa-Responsive Parkinsonism with Pyramidal Signs Due to ATP13A2, PLA2G6, FBXO7 and Spatacsin Mutations
Paisan-Ruiz C., Guevara R., Federoff M., Hanagasi H. A., Sina F., Elahi E., et al.
MOVEMENT DISORDERS
, cilt.25, sa.12, ss.1791-1800, 2010 (SCI-Expanded, Scopus)
2010
201036. Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study
Eggert K., Squillacote D., Barone P., Dodel R., Katzenschlager R., Emre M., et al.
MOVEMENT DISORDERS
, cilt.25, sa.7, ss.896-905, 2010 (SCI-Expanded, Scopus)
2010
201037. Effects of Rivastigmine in Alzheimer's Disease Patients with and Without Hallucinations
Cummings J., Emre M., Aarsland D., Tekin S., Dronamraju N., Lane R.
JOURNAL OF ALZHEIMERS DISEASE
, cilt.20, sa.1, ss.301-311, 2010 (SCI-Expanded, Scopus)
2010
201038. Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease
Emre M., Bernabei R., Blesa R., Bullock R., Cunha L., Daniels H., et al.
CNS NEUROSCIENCE & THERAPEUTICS
, cilt.16, sa.4, ss.246-253, 2010 (SCI-Expanded, Scopus)
2009
200939. Memantine: a new hope for treatment of Lewy body-related dementias?
Emre M.
LANCET NEUROLOGY
, cilt.8, sa.7, ss.594-595, 2009 (SCI-Expanded)
2009
200940. Psychotic and Compulsive Symptoms in Parkinson's Disease
Verbaan D., van Rooden S. M., Visser M., Marinus J., Emre M., van Hilten J. J.
MOVEMENT DISORDERS
, cilt.24, sa.5, ss.738-744, 2009 (SCI-Expanded, Scopus)
2009
200941. BuChE-K and APOE epsilon 4 Allele Frequencies in Lewy Body Dementias, and Influence of Genotype and Hyperhomocysteinemia on Cognitive Decline
Lane R., He Y., Morris C., Leverenz J. B., Emre M., Ballard C.
MOVEMENT DISORDERS
, cilt.24, sa.3, ss.392-400, 2009 (SCI-Expanded, Scopus)
2009
200942. MITOCHONDRIAL PATHOLOGY IN MUSCLE OF A PATIENT WITH A NOVEL PARKIN MUTATION
Hanagasi H. A., Serdaroglu P., Ozansoy M., Basak N., Tasli H., Emre M.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, cilt.119, sa.10, ss.1572-1583, 2009 (SCI-Expanded, Scopus)
2008
200843. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease
Emre M., Mecocci P., Stender K.
JOURNAL OF ALZHEIMERS DISEASE
, cilt.14, sa.2, ss.193-199, 2008 (SCI-Expanded, Scopus)
2008
200844. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia - A retrospective analysis of a double-blind trial and an open-label extension
Oertel W., Poewe W., Wolters E., De Deyn P. P., Emre M., Kirsch C., et al.
DRUG SAFETY
, cilt.31, sa.1, ss.79-94, 2008 (SCI-Expanded, Scopus)
2008
200845. Parkinson's Disease Dementia: Definitions, Guidelines, and Research Perspectives in Diagnosis
Goetz C. G., Emre M., Dubois B.
ANNALS OF NEUROLOGY
, cilt.64, sa.6, 2008 (SCI-Expanded, Scopus)
2007
200746. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the Movement Disorder Society Task Force
Dubois B., Burn D., Goetz C., Aarsland D., Brown R. G., Broe G. A., et al.
MOVEMENT DISORDERS
, cilt.22, sa.16, ss.2314-2324, 2007 (SCI-Expanded, Scopus)
2007
200747. Subthreshold depression in patients with Parkinson's disease and dementia - clinical and demographic correlates
Ehrt U., Bronnick K., De Deyn P. P., Emre M., Tekin S., Lane R., et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
, cilt.22, sa.10, ss.980-985, 2007 (SCI-Expanded, SSCI, Scopus)
2007
200748. Clinical diagnostic criteria for dementia associated with Parkinson's disease
Emre M., Aarsland D., Brown R., Bum D. J., Duyckaerts C., Mizuno Y., et al.
MOVEMENT DISORDERS
, cilt.22, sa.12, ss.1689-1707, 2007 (SCI-Expanded)
2007
200749. Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: Similarities and differences
Emre M., Cummings J. L., Lane R. M.
JOURNAL OF ALZHEIMERS DISEASE
, cilt.11, sa.4, ss.509-519, 2007 (SCI-Expanded, Scopus)
2007
200750. Association between vitamin D receptor gene polymorphism and Alzheimer's disease
Gezen-Ak D., Dursun E., Ertan T., Hanagasi H. A., Guervit H., Emre M., et al.
Tohoku Journal of Experimental Medicine
, cilt.212, sa.3, ss.275-282, 2007 (SCI-Expanded, Scopus)
2007
200751. Neurosyphilis presenting with status epilepticus
Gurses C., Kurtuncu M., Jirsch J., Yesilot N., Hanagasi H. A., Bebek N., et al.
EPILEPTIC DISORDERS
, cilt.9, sa.1, ss.51-56, 2007 (SCI-Expanded, Scopus)
2007
200752. Clinical and magnetic resonance imaging findings of HIV-Negative patients with neurosyphilis
GÜRSES C., Bilgic B., TOPÇULAR B., TUNCER O. G., AKMAN-DEMIR G., HANAGASI H. A., et al.
Journal of Neurology
, cilt.254, sa.3, ss.368-374, 2007 (SCI-Expanded, Scopus)
2007
200753. Smoking-responsive juvenile-onset parkinsonism
Hanagasi H. A., Lees A., Johnson J. O., Singleton A., Emre M.
MOVEMENT DISORDERS
, cilt.22, sa.1, ss.115-118, 2007 (SCI-Expanded, Scopus)
2006
200654. Characterizing clinical phenotypes - The Lewys in their life or the life of their Lewys?
Lippa C. F., Emre M.
NEUROLOGY
, cilt.67, sa.11, ss.1910-1911, 2006 (SCI-Expanded, Scopus)
2006
200655. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
Burn D., Emre M., McKeith I., De Deyn P. P., Aarsland D., Hsu C., et al.
MOVEMENT DISORDERS
, cilt.21, sa.11, ss.1899-1907, 2006 (SCI-Expanded, Scopus)
2006
200656. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease
Dogru-Abbasoglu S., INCEOGLU M., PARILDAR-KARPUZOGLU H., HANAGASI H. A., KARADAG B., GURVIT H., et al.
NEUROSCIENCE LETTERS
, sa.3, ss.258-261, 2006 (SCI-Expanded, Scopus)
2006
200657. Dementia: From basics to the clinical syndrome
Emre M.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
, cilt.61, sa.3, ss.306, 2006 (SCI-Expanded, SSCI, Scopus)
2006
200658. Comparative analysis of event-related potentials during Go/NoGo and CPT: Decomposition of electrophysiological markers of response inhibition and sustained attention
KIRMIZI-ALSAN E., Bayraktaroglu Z., Gurvit H., Keskin Y. H., EMRE M., Demiralp T.
Brain Research
, cilt.1104, sa.1, ss.114-128, 2006 (SCI-Expanded, Scopus)
2006
200659. Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves G., Petter Larsen J., Emre M., Wentzel-Larsen T., Aarsland D.
MOVEMENT DISORDERS
, cilt.21, sa.8, ss.1123-1130, 2006 (SCI-Expanded, Scopus)
2006
200660. Rivastigmine in Parkinson's disease dementia - A viewpoint by Murat Emre
Emre M.
CNS DRUGS
, cilt.20, sa.9, ss.748, 2006 (SCI-Expanded, Scopus)
2005
200561. Late-Onset Presentation of Ornithine Transcarbamylase Deficiency in a 65-Year-Old Female Patient
ÇOBAN A., Gurses C., Hanagasi H. A., Aminpoor P., BAYKAL B., GÜRVİT İ. H., et al.
EPILEPSI
, cilt.11, sa.1, ss.22-28, 2005 (ESCI, TRDizin)
2000
200062. Spinoserebellar ataksi tip-2’li bir Türk ailesinde klinik ve moleküler analiz
HANAĞASI H. A., Ersoy N., BİLGİÇ B., SAHIN H., Annesi G., GÜRVİT İ. H., et al.
Parkinson Hastalığı ve Hareket Bozuklukları Dergisi , cilt.1, sa.1, ss.39-44, 2000 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2017
20171. The Comparison of Gait and Balance Parameters According To The Findings of Cognitive Impairment, Falling and Freezing of Gait I Patients With Parkinson Disease
ERSÖZ HÜSEYİNSİNOĞLU B., ZİREK E., TÜFEKÇİOĞLU Z., BİLGİÇ B., HANAĞASI H. A., EMRE M.
Neurorehabilitation and Neural Repair, Maastricht, Hollanda, 22 Mayıs - 24 Eylül 2017, ss.87, (Tam Metin Bildiri)
2016
20162. Parkinson Hastalarında Yürüme ve Denge PArametrelerinin Kognisyon, Düşme ve Donma Bulgularına Göre Karşılaştırılması
ERSÖZ HÜSEYİNSİNOĞLU B., ZİREK E., TÜFEKÇİOĞLU Z., BİLGİÇ B., HANAĞASI H. A., EMRE M.
52. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 25 Kasım - 01 Aralık 2016, ss.310, (Tam Metin Bildiri)
2016
20163. An fMRI investigation of the neural correlates underlying football fanaticism
Makar Ç. C., KURT E., BİLGİÇ B., Ulaşoğlu Yıldız Ç., BÜYÜKGÖK D., EMRE M.
14. Ulusal Sinirbilim Kongresi, Ankara, Türkiye, 26 - 29 Mayıs 2016, ss.69-70, (Tam Metin Bildiri)
2013
20134. DEMENTIA IN PARKINSON'S DISEASE
Emre M.
6th International Conference on Alzheimers Disease and Related Disorders in the Middle East, İstanbul, Türkiye, 25 - 27 Ekim 2013, cilt.35, ss.716, (Özet Bildiri)
2008
20085. Effects of memantine on memory and language functions in Alzheimer's disease
Emre M.
12th Congress of the European-Federation-of-Neurological-Societies, Madrid, İspanya, 23 - 26 Ağustos 2008, cilt.15, ss.414, (Özet Bildiri)
2005
20056. Clinical features and treatment of dementia associated with Parkinson's disease
Emre M.
7th International Conference on Progress in Alzheimers and Parkinsons Disease, Sorrento, İtalya, 9 - 13 Mart 2005, cilt.57, ss.1-7, (Tam Metin Bildiri)
0
07. Vitamin D receptor, Presenilin 1 and interleukin 1 alpha gene SNPs and late-onset Alzheimer’s disease
DURSUN E., GEZEN AK D., Uysal Ö., ERTAN T., Bilgiç B., GÜRVİT İ. H., et al.
10th International Conference on Alzheimer’s Disease and Related Disorders, İspanya, cilt.2, ss.197, (Özet Bildiri)
0
08. SNPs at the ligand binding site of the vitamin D receptor gene and Alzheimer’s disease.
GEZEN AK D., DURSUN E., ERTAN T., HANAĞASI H. A., Gürvit H., Emre M., et al.
10th International Conference on Alzheimer’s Disease and Related Disorders,, İspanya, cilt.2, sa.3, ss.195-0, (Tam Metin Bildiri)
0
09. Polymorphisms at the Ligand Binding Sites of Vitamin D Receptor Gene and Alzheimer’s Disease
GEZEN AK D., DURSUN E., ERTAN T., HANAĞASI H. A., Gürvit H., Emre M., et al.
21st International Conference of Alzheimer’s Disease International, Türkiye, ss.50, (Tam Metin Bildiri)
0
010. Interleukin 1 Alpha Gene 5’ Regulatory Region Polymorphism in Alzheimer's Disease.
DURSUN E., GEZEN AK D., ERTAN T., Bilgiç B., Gürvit H., Emre M., et al.
European Human Genetics Conference 2005, Çek Cumhuriyeti, cilt.13, sa.1, ss.338, (Tam Metin Bildiri)
0
011. Interleukin1? Gene C(-889)T Polymorphism in Late-onset
GEZEN AK D., DURSUN E., ERTAN T., Bilgiç B., Gürvit H., Emre M., et al.
Alzheimer's Disease. 9th International Conference on Alzheimer’s Disease and Related Disorders, Philadelphia USA, Amerika Birleşik Devletleri, cilt.25, ss.504, (Tam Metin Bildiri)
Kitaplar
2014
20141. . Dementia with Lewy bodies and Parkinson’s disease dementia
HANAĞASI H. A., BİLGİÇ B., EMRE M.
dementia, comprehensive princi.ples and practices, bradford Dickerson, Alireza Atri, Editör, Oxford University Press, London , Newyork, ss.231-259, 2014
2013
20132. Parkinson's Disease Dementia
BİLGİÇ B., HANAĞASI H. A., EMRE M.
Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders, Aarsland D., Cummings J., Weintraub D., Chaudhur, R., Editör, Cambridge University Press, Cambridge (MA), USA , Newyork, ss.177-191, 2013
2012
20123. Özel konstellasyonlar
BİLGİÇ B., EMRE M.
Nöroloji Temel Kitabı, Emre M., Editör, Güneş Tıp Kitape, Ankara, ss.1010-1013, 2012